Administration of TNF-α neutralizing antibody to patients with type 2 diabetes does not reduce their insulin resistance (30, 31), suggesting that the inflammatory process could be a result of obesity, but not a cause of insulin resistance or diabetes. This evidence concerns the gene TNF and type 2 diabetes mellitus.